Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.48ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.48ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.48EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.48EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.48ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.112EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.112EWon-ECACACAATCGATGCGCAGTA20502636526346R-8964.71South Korea
B.1.112ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.112ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.112EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.112EHuang-EGCAGCAGTACGCACACAATC20552637626357R-15066.9China
B.1.112ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.112ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.274EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.274EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.274ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.274ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
B.1.274EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
B.1.274EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
B.1.274ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.274ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.515EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.515EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.515ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.515ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.515EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.515EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.515ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.515ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.24.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.24.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.24.1 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.24.1 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.24.1 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.24.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.24.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.24.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.492EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.492EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.492ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.492ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.492EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.492EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.492ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.492ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.540EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.540EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.540ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.540ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used